Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Bucknelly21on Jul 31, 2022 9:55pm
99 Views
Post# 34863552

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Comparing Corporate Presentations

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Comparing Corporate Presentations

totally agree that was a job well done 


realitycheck4u wrote: However, let's at the very least applaud the c-suite for doing the marathon deal.  I am happy to pay the 10% risk fee, as I don't think they'll be paying it for long.  Inthink 1902 works and they do a China deal to pay that amount back and the balance of the convert.  
 

Bucknelly21 wrote: To be fair i will say i think that the most impressive person by far is christian, he is why im hanging in there, he is really the onky person i have 100% faith in at thera. I think paul is either dishonest or he just gets ahead of himself. Phillipe thinks everyone but himself is wrong about the capital markets. I was a huge fan of what this company was doing 5 years ago when i   First invested in thera. Over that period of time the company's actions have eroded alot of that. Spceo knows why as do most of you all. I still have hope that christian delivers something ao big that the c suite wont be able to blow it up. You are correct however i am negative but as you watch them from a market perspective blow opportunity after opportunity with no corrections to their strategy it obviously will aftect a perspective of the investment. Hence why no one is paying attention beside this tiny group on a random message board. They pumped wino full of lies, paul lied to spceo about a non dilution financing. So appologies if my negativity comes across as pointless but i think its well justified given the current situation thera has with markets, coverage and the way they treat shareholders.




<< Previous
Bullboard Posts
Next >>